MELMISAT owner Contact Information online
from Delcath Systems, Inc.
MELMISAT
US serial number:85181614
Application filling date:Nov. 19, 2010
Register:Principal
Mark type:Trademark, Service Mark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jun. 24, 2013
Publication date:Mar. 29, 2011
Abandoned date:Jun. 24, 2013
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical products for the treatment of cancer
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
For: Medical research services in the field of cancer
International Class(es): 04
Services:Pharmaceutical products for the treatment of cancer
Current owner owner name:Delcath Systems, Inc.
Current owner owner address:810 Seventh Avenue, 35th Floor
New York,
NEW YORK
UNITED STATES
10019
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:James H. Donoian
Attorney email:nytmdkt@gtlaw.com
Attorney docket number:066964.02000
Attorney email authorized:Yes
Correspondent name address:JAMES H. DONOIAN
GREENBERG TRAURIG, LLP
200 PARK AVE FL 14
NEW YORK,
NEW YORK
UNITED STATES
10166-1400
Correspondent phone:212.801.2140
Correspondent email:nytmdkt@gtlaw.com
Correspondent fax:212.801.6400
Correspondent email authorized:Yes
Trademark staff tm attorney:LOTT, MAUREEN DALL
Trademark staff law office assigned MELMISAT:LAW OFFICE 117
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (131) JOHNSON & JOHNSON (127) Millennium Pharmaceuticals, Inc. (55) Eli Lilly and Company (51) Windmill Health Products, LLC (47) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) S. C. Johnson & Son, Inc. (30) Primary Investments Group Limited (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) Western Holdings, LLC (21) MONSTER ENERGY COMPANY (19) Scott Riddell (17)Popular publication dates
Mar. 29, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
